Urinary Tumor Markers for Bladder Cancer
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Oklahoma Policy CPCPLAB038 alerts
Get alerted when Policy CPCPLAB038 changes without checking for updates manually.
Monitor payer policy activity
Defines reimbursement and coding criteria for urinary biomarker tests used in diagnosis and surveillance of bladder cancer for Blue Cross Blue Shield - Oklahoma members and providers.
Removed codes 0012M, 0013M, 0363U, 0420U, 0452U, 0465U, 0549U.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.